-
Business
-
Policy & Business
-
-
Federal IT
-
Information Technology
-
-
State & Local
-
State & Local Government
-
-
Defense
-
Defense & Intelligence
-
-
Healthcare
-
Healthcare Policy & IT
-
-
Energy
-
Energy Policy & Technology
-
-
Education
-
Education Policy & Technology
-
F.D.A. Approves New Version of Cervical Cancer Vaccine
The New York Times: The drug maker Merck received approval on Wednesday for an updated version of its Gardasil vaccine, which protects against the virus that causes most cases of cervical cancer.
Tags
Share
Top Stories
- The ‘Gateway Drug to Corruption and Overspending’ Is Returning to Congress – but Are Earmarks Really that Bad?
- Trump asked Georgia secretary of state to 'find' 11.7k ballots, recalculate election result
- Pelosi Is Narrowly Reelected Speaker
- U.S. appeals court rejects lawmaker's bid to have Pence overturn Biden's win
- Biden Team Says It's Facing 'Pockets of Resistance' in Transition
- Supreme Court Punts Census Case, Giving Trump An Iffy Chance To Alter Numbers
- Watchdog Finds Education Department’s Return to Office Plan is Generally Good
- Pete Buttigieg Could Become the First Senate-Approved out LGBTQ + Cabinet Secretary
- GovExec Daily: What Federal Execs Can Expect During the Transition
- Biden's Victory Cemented As States Reach Key Electoral College Deadline
- Trump's Legal Losses Come Fast And Furious
- Senators Raise Concerns Over Burrowing In, Other 'Midnight' Activities at VA
- How Dozens of Trump’s Political Appointees Will Stay in Government After Biden Takes Over
- Biden officially announces ex-Obama official Brian Deese as top economic adviser
- US lawmakers unveil anti-slavery constitutional amendment
- U.S. Senate panel votes to approve Trump FCC nominee
Whitepapers & Special Reports
i360Gov Newsletters
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe NowAlso in Policy & Business
About
i360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Contact Us
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
Newsletters
Copyright © 2009-2025 i360Communications, LLC.